"Designing Growth Strategies is in our DNA"
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Bacterial Skin Infections- By key countries,2018
4.2. New Product Launch
4.3. Pipeline Analysis
4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2018
5. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Infection Type
5.2.1. Hospital-acquired ABSSSI
5.2.2. Community-acquired ABSSSI
5.3. Market Analysis, Insights and Forecast – By Route of Administration
5.3.1. Oral
5.3.2. Parenteral
5.4. Market Analysis, Insights and Forecast – By Distribution Channel
5.4.1. Hospital Pharmacy
5.4.2. Retail Pharmacy
5.4.3. Online Pharmacy
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Infection Type
6.2.1. Hospital-acquired ABSSSI
6.2.2. Community-acquired ABSSSI
6.3. Market Analysis, Insights and Forecast – By Route of Administration
6.3.1. Oral
6.3.2. Parenteral
6.4. Market Analysis, Insights and Forecast – By Distribution Channel
6.4.1. Hospital Pharmacy
6.4.2. Retail Pharmacy
6.4.3. Online Pharmacy
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Infection Type
7.2.1. Hospital-acquired ABSSSI
7.2.2. Community-acquired ABSSSI
7.3. Market Analysis, Insights and Forecast – By Route of Administration
7.3.1. Oral
7.3.2. Parenteral
7.4. Market Analysis, Insights and Forecast – By Distribution Channel
7.4.1. Hospital Pharmacy
7.4.2. Retail Pharmacy
7.4.3. Online Pharmacy
7.5. Market Analysis, Insights and Forecast – By Country/Sub-Region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Infection Type
8.2.1. Hospital-acquired ABSSSI
8.2.2. Community-acquired ABSSSI
8.3. Market Analysis, Insights and Forecast – By Route of Administration
8.3.1. Oral
8.3.2. Parenteral
8.4. Market Analysis, Insights and Forecast – By Distribution Channel
8.4.1. Hospital Pharmacy
8.4.2. Retail Pharmacy
8.4.3. Online Pharmacy
8.5. Market Analysis, Insights and Forecast – By Country/Sub-Region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Infection Type
9.2.1. Hospital-acquired ABSSSI
9.2.2. Community-acquired ABSSSI
9.3. Market Analysis, Insights and Forecast – By Route of Administration
9.3.1. Oral
9.3.2. Parenteral
9.4. Market Analysis, Insights and Forecast – By Distribution Channel
9.4.1. Hospital Pharmacy
9.4.2. Retail Pharmacy
9.4.3. Online Pharmacy
9.5. Market Analysis, Insights and Forecast – By Country/Sub-Region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10 Middle East & Africa Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis, Insights and Forecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis, Insights and Forecast – By Infection Type
10.2.1. Hospital-acquired ABSSSI
10.2.2. Community-acquired ABSSSI
10.3. Market Analysis, Insights and Forecast – By Route of Administration
10.3.1. Oral
10.3.2. Parenteral
10.4. Market Analysis, Insights and Forecast – By Distribution Channel
10.4.1. Hospital pharmacy
10.4.2. Retail Pharmacy
10.4.3. Online Pharmacy
10.5. Market Analysis, Insights and Forecast – By Country/Sub-Region
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2018)
11.3. Company Profiles (Overview, Products & services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
11.3.1. Merck & Co., Inc.
11.3.2. Pfizer Inc.
11.3.3. MELINTA THERAPEUTICS, INC.
11.3.4. ALLERGAN
11.3.5. Paratek Pharmaceuticals, Inc.
11.3.6. Cumberland Pharmaceuticals Inc.
11.3.7. Teva Pharmaceutical Industries Ltd.
11.3.8. Others
12. Strategic Recommendations